On December 15, 2025, Swedish Orphan Biovitrum AB (Sobi), a global biopharma company based in Stockholm, announced that it has... Read more
Major Biotech Deal: Sobi Acquires Arthrosi in Transaction Valued Up to $1.5 Billion
15/12/2025
Published by vivi
